Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2006; 12(48): 7837-7843
Published online Dec 28, 2006. doi: 10.3748/wjg.v12.i48.7837
Published online Dec 28, 2006. doi: 10.3748/wjg.v12.i48.7837
Factor | Re-bleeding (n) | P | OR (95% CI) |
Co-existing illness | 5 | 0.288 | 2.3 (0.6-8.8) |
Hematemesis | 6 | 0.971 | 0.8 (0.2-3.6) |
Smoking | 5 | 0.490 | 1.9 (0.4-7.3) |
Aspirin/NSAIDs | 7 | 0.721 | 1.1 (0.3-8.7) |
Age ≥ 65 yr | 5 | 0.117 | 2.1 (0.7-10.8) |
Ulcer size > 1 cm | 6 | 0.001 | 11 (2.6-46.3) |
Ulcer locations: | |||
Posterior duodenal | 4 | 0.041 | 7 (1.5-18.2) |
Gastric corporal | 3 | 0.049 | 5 (1.0-14.3) |
Ulcer stigmata: | |||
Flat spots | 5 | 0.001 | 12 (4.5-57.3) |
Old clots | 3 | 0.023 | 5 (1.2-13.5) |
-
Citation: Yılmaz Ş, Bayan K, Tüzün Y, Dursun M, Canoruç F. A head to head comparison of oral
vs intravenous omeprazole for patients with bleeding peptic ulcers with a clean base, flat spots and adherent clots. World J Gastroenterol 2006; 12(48): 7837-7843 - URL: https://www.wjgnet.com/1007-9327/full/v12/i48/7837.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i48.7837